RetinaLyze International

Rutevejledning Website Kontakt virksomheden

RetinaLyze International Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine.

19/10/2026

A fundus image is captured. What happens next?

That's the question in the third film from our cooperation with EYS. Sondre Enger Beckrøge walks through the actual workflow, and Teddy Birch Petersen asks the follow-ups.

The image goes into Eys. From there you have three routes. Run it through RetinaLyze AI for signs of diabetic retinopathy, AMD and glaucoma. Send it digitally to a doctor for verification, diagnosis or treatment. Or do both: analyse first, then have a doctor verify the result.

The practical difference is that it's now one platform instead of two. Images and patient information get uploaded once, not twice.

Sondre also talks about where this is heading. EYS is working on connecting journal systems and cameras to the same platform, with the goal that analysing an image and sending it onward takes a single click.

Which of the three routes would you use most in your practice?

New device integration: ZEISS VISUREF 1000RetinaLyze now works with the ZEISS VISUREF 1000, the screening station that c...
14/10/2026

New device integration: ZEISS VISUREF 1000

RetinaLyze now works with the ZEISS VISUREF 1000, the screening station that combines refraction, topography, tonometry and pachymetry with 45° non-mydriatic fundus imaging.

The fundus images the VISUREF 1000 captures during the exam go straight into RetinaLyze, so the same visit that measures refraction and pressure also checks the retina for signs of pathology, with the result back in about 45 seconds and the reasoning shown.

What this means for a practice or a chain:
One visit, one workflow. The screening runs on the station you already have, without a second device.
Referral built in. Send a case to an ophthalmologist for a second opinion without leaving the room.
The same result everywhere. Objective, reproducible outputs across locations, operators and time.

The AI analyses. You decide. RetinaLyze detects signs of pathology; it does not diagnose and does not replace an examination.

If you use the VISUREF 1000 today, book a demo and we will set you up: https://retinalyze.com/free-trial/

12/10/2026

Not every case needs an ophthalmologist. Working out which ones do is the hard part.

In the second film from our cooperation with EYS, Teddy Birch Petersen asks Sondre Enger Beckröge what customers actually need from AI in eye care right now.

His answer is about volume. Patient numbers keep climbing, so the clinical market has to work more efficiently, and sending every case onward to an ophthalmologist isn't efficient. That's where AI fits: fast triage, sorting who genuinely needs a specialist from who doesn't.

He's also direct about the risk. The permanent tension in healthcare is between clinical excellence and efficiency. Technical, regulatory and operational problems can usually be solved. The one to watch is efficiency quietly eating into clinical quality.

And the pressure isn't easing. As populations age, cases of AMD, glaucoma and diabetic retinopathy will keep growing. The underlying need doesn't change. The volume does.

Where do you feel that squeeze most: the quality side or the capacity side?

Over a billion people still can't get the eye care they need. World Sight Day, on Thursday 8 October, is a yearly remind...
08/10/2026

Over a billion people still can't get the eye care they need. World Sight Day, on Thursday 8 October, is a yearly reminder that most of that gap is solvable.

The IAPB puts its goal in three words: accessible, available, affordable. For a lot of people in Europe, the most accessible eye care is the optician on their high street. You don't need a referral, and many are open on Saturdays.

That makes it one of the best places to catch disease early, as long as the practice has the right tools. Since 2013, RetinaLyze has analysed fundus photos and OCT scans in optical stores, eye clinics and hospitals. We've now passed 7 million screenings, and a new one finishes about every 35 seconds.

Behind each of those is a person who got a result in around 45 seconds. If something looks wrong, the optometrist can ask an ophthalmologist and send a digital referral without leaving the system.

Software alone won't fix access. Someone still takes the photo, explains the result, and makes sure the referral lands. What it changes is that a proper check no longer depends on having a specialist in the building.

This year's World Sight Day challenge asks people to take eye care into a school, a workplace, or a room where policy is made. We'd add one more place: the shop down the street.

How is your practice marking World Sight Day this year?

Back from Vienna. One observation, and one thing we got wrong.The observation: nobody at B60 asked whether AI screening ...
06/10/2026

Back from Vienna. One observation, and one thing we got wrong.

The observation: nobody at B60 asked whether AI screening works. Four days, a lot of conversations, not one "does it actually detect anything." Two years ago that was half the questions. The debate has moved to where the result lands, who acts on it, and whether it fits a referral pathway that already exists. That's a healthier debate, and a harder one.

What we got wrong: we came prepared to talk about the AI, and most people wanted to talk about the connection. Topcon Harmony pulling the image from the camera, handing it to RetinaLyze, and putting the answer back in the record without anyone touching a file.

Euretina now has a Special Focus Meeting on AI in retina behind it and another AI event on the calendar for 2027. AI has stopped being a session and started being a line item in a workflow. That suits us. It's the boring part we've been arguing about for years.

Thank you to Topcon Healthcare for the stand and to everyone who stopped, asked awkward questions and stayed for the answer. Same time next year.

Day two in Vienna. A question we keep getting at B60:"How many clicks?"One. In the Harmony viewer, you open the image, c...
02/10/2026

Day two in Vienna. A question we keep getting at B60:
"How many clicks?"

One. In the Harmony viewer, you open the image, choose RetinaLyze, and the analysis comes back into the same patient record. That's the demo, and it takes about as long to show as it did to read this.

The better question, which fewer people ask, is what happens on a bad day. The image is slightly out of focus. The pupil was small. The patient is 84 and has early cataract. RetinaLyze flags the image as ungradable rather than forcing a result out of it, and the retake happens while the patient is still in the chair, because the result is right there in the workflow rather than in an email three days later.

That second part is why the integration matters more than the AI. A great algorithm behind a clumsy workflow gets used twice and forgotten. A decent workflow gets used every day.

EURETINA has 140-plus nationalities in one building this week. The screening capacity behind those delegates varies enormously. That's a good reason to talk about plumbing, not just performance.

Topcon Healthcare, booth B60, until Sunday.

Every referral that lands on your desk started as an image someone else took.An optometrist. A diabetes nurse. A GP prac...
29/09/2026

Every referral that lands on your desk started as an image someone else took.
An optometrist. A diabetes nurse. A GP practice with a fundus camera in the corner.

That photo had one job: decide whether the patient needs you or not.
The weak point is rarely the camera or the algorithm.

It's the handling in between. Export the image. Move it to a folder. Upload it. Wait. Copy the result back into the record. Each step is a place where a patient slips through, or where a busy practice quietly stops bothering.

At EURETINA in Vienna, Topcon Healthcare will show what changes when the camera, the record and the analysis sit in one place. A Topcon fundus camera feeds Harmony. Harmony passes the image to RetinaLyze.

The RetinaLyze DR, AMD and Glaucoma results return to the same viewer, in the same record. No folders, no re-uploading.

For you, the interesting part isn't the AI. It's what arrives afterwards: a referral with a structured screening result already attached, rather than a photo and a hunch.

Come by Booth B60, 1–4 October.

27/09/2026

The retina is about as thick as a sheet of paper. Everything you see today passes through it.

It lines the back of the eye and turns light into the signals your brain reads as faces, road signs, the text on this screen. It has no pain receptors. So when something goes wrong, there is usually no warning. Diabetic retinopathy and age-related macular degeneration can progress for years without symptoms you'd notice. Glaucoma, which damages the optic nerve at the back of the eye, behaves the same way. By the time vision changes, some of the damage is often permanent.

That's why World Retina Day is worth marking. Most of what threatens it can be spotted early, and early is when treatment still works.

The people doing that spotting deserve a thank you today. Optometrists taking a retinal photo between two pairs of glasses. Screening nurses working through a diabetes clinic's morning list. Ophthalmologists and retina specialists making the decisions that follow. Researchers who spend years on a single question. Patient organisations making sure nobody gets a diagnosis alone. GPs and diabetes nurses who keep reminding people to book the appointment.

At RetinaLyze we stand a step behind all of them, helping to read fundus images since 2013. We see every day how much depends on someone, somewhere, deciding to take the photo.

If you have diabetes, a family history of eye disease, or just haven't had your eyes checked in a couple of years, book an eye exam. It takes minutes and it doesn't hurt.

Happy World Retina Day, and thank you to everyone who looks after the back of the eye.

23/09/2026

We've known EYS since 2016. We've shared the same customers for nearly as long. We just never connected the two systems.

Until now.

In this short video, Sondre Enger Beckröge (CEO, EYS) and Teddy Birch Petersen (CEO, RetinaLyze) talk about why the cooperation happened now and what changes for the people using both products every day.

The short version: EYS connects opticians to ophthalmologists so patients can be handled safely between them. RetinaLyze analyses the images. Until now that meant two systems, two tabs, both open during a consultation. With the integration in place, it's one.

Sondre has tested it himself and says it works well. We've shown it to a handful of customers, and the next step is getting it into their hands, listening to what comes back, and improving it from there.

If you're already using both, or you've been juggling systems mid-consultation, we'd like to hear from you.

New device integration: iCare DRSplus RetinaLyze now works with the iCare DRSplus, the TrueColor confocal fundus imaging...
21/09/2026

New device integration: iCare DRSplus

RetinaLyze now works with the iCare DRSplus, the TrueColor confocal fundus imaging system. Capture on the DRSplus, analyse with RetinaLyze, and have signs of pathology flagged in about 45 seconds, with the reasoning shown.

The DRSplus captures a 45° field through a 2.5 mm pupil without dilation, and its auto-alignment, auto-focus and auto-capture mean the screening fits into the appointment you already have.

What this means for a practice or a chain: One workflow. Images move from the DRSplus into RetinaLyze for analysis and the patient report. Referral built in. Send a case to an ophthalmologist for a second opinion without leaving the room.

The same result everywhere.

Objective, reproducible outputs across locations, operators and time. The AI analyses. You decide. RetinaLyze detects signs of pathology; it does not diagnose and does not replace an examination.

If you use the DRSplus today, book a demo and we will set you up: https://retinalyze.com/free-trial

Adresse

Lyskær 1
Skovlunde
2730

Åbningstider

Mandag 09:00 - 17:30
Tirsdag 09:00 - 17:30
Onsdag 09:00 - 17:30
Torsdag 09:00 - 17:30
Fredag 09:00 - 17:30

Website

Underretninger

Bliv den første, der får besked: Vi sender dig en e-mail, når RetinaLyze International offentliggør nyheder og tilbud. Din e-mailadresse bliver ikke brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Virksomheden

Send en besked til RetinaLyze International:

Genveje

Del